Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Midline Versus Dorsolateral Spinal Cord Stimulation for Post-surgical Neuropathic Pain (MIDL-SCS Trial)

NCT06390150 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT06390150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06390150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Midline Versus Dorsolateral Spinal Cord Stimulation for Post-surgical Neuropathic Pain (MIDL-SCS Trial)
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
July 31, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain, pain, postoperative